A 69-year-old ex-smoker with COPD (FEV₁ 50% predicted) has daily symptoms and two exacerbations requiring oral corticosteroids in the last year despite regular long-acting muscarinic antagonist (LAMA) and long-acting β₂-agonist (LABA) inhalers. According to COPD guidelines, which escalation is most appropriate?